⌕
Cerus · CERS · Nasdaq
Tenet 33 · Weak
Compare
$1.99+2.32%At closeTenet 33 · Weak
$1.99+0.05 (+2.32%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Cerus (CERS) Stock

Cerus (CERS) closed at $1.99 on Nov 13, 2026; its Tenet Score is 33 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Previous close
$1.99
Nov 13, 2026
Market cap
$400.9M
share price × the latest quarter's diluted weighted-average share count (vendor)
Dividend yield
0.00%
reinvests all
52-week range
1.47 – 3.47
low → high
Tenet Score
33/100
Weak · 409 Healthcare peers

Industry: Drugs · see every company filed here →

CERUS CORP scores 33/100. Weak. Value is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
33/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
20
Quality
38
Health
23
Growth
51

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityDHealthFGrowthCMomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
5.3×
cap ÷ Sep 30, 2026 book value, Nov 13, 2026 close
P/S
1.7×
price to fiscal 2025 sales
ROE
−11%
TTM through Sep 30, 2026
Operating margin
−3.7%
fiscal 2025, before interest and tax
Net margin
−3.2%
TTM through Sep 30, 2026
Current ratio
1.96
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not reported in the company's filings for this period.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About CERUS CORP

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replicatio…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 50 US ETFs · top wrappers by weightSee all ETFs holding CERS →

What sector and industry is Cerus in?

Cerus is in the Healthcare sector and the Drugs industry.

What is Cerus' Tenet Score?

Cerus' Tenet Score is 33 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.